. 2022 May;197(4):497-501.


doi: 10.1111/bjh.18145.


Epub 2022 Mar 22.

Collaborators,

Affiliations

Item in Clipboard

Maurice Swinkels et al.


Br J Haematol.


2022 May.

Abstract

Von Willebrand disease (VWD) is a bleeding disorder caused by quantitative (type 1 or 3) or qualitative (type 2A/2B/2M/2N) defects of circulating von Willebrand factor (VWF). Circulating VWF levels not always fully explain bleeding phenotypes, suggesting a role for alternative factors, like platelets. Here, we investigated platelet factor 4 (PF4) in a large cohort of patients with VWD. PF4 levels were lower in type 2B and current bleeding phenotype was significantly associated with higher PF4 levels, particularly in type 1 VWD. Based on our findings we speculate that platelet degranulation and cargo release may play a role across VWD subtypes.


Keywords:

VWD; VWF; bleeding disorders; platelet activation; platelet factor 4.

References

REFERENCES

    1. Leebeek FW, Eikenboom JC. Von Willebrand’s disease. N Engl J Med. 2016;375(21):2067–80.

    1. Springer TA. von Willebrand factor, Jedi knight of the bloodstream. Blood. 2014;124(9):1412–25.

    1. de Wee EM, Sanders YV, Mauser‐Bunschoten EP, van der Bom JG, Degenaar‐Dujardin ME, Eikenboom J, et al. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost. 2012;108(4):683–92.

    1. Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, et al. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016;127(20):2481–8.

    1. Karampini E, Bierings R, Voorberg J. Orchestration of primary hemostasis by platelet and endothelial lysosome‐related organelles. Arterioscler Thromb Vasc Biol. 2020;40(6):1441–53.